DENV-3 precursor membrane (prM) glycoprotein enhances E protein immunogenicity and confers protection against DENV-2 infections in a murine model
To improve a DNA vaccine containing the truncated dengue virus serotype 2 (DENV-2) envelope (E) protein and evaluate the influence of precursor membrane (prM) glycoprotein polymorphism on E protein immunogenicity, two vaccine candidates have been constructed by upstream insertion of the DENV-2 and D...
Main Authors: | Roberto S. Dias, Michelle D. Teixeira, Mariana F. Xisto, John W. O. Prates, Jessica D. Da Silva, Iago O. Mello, Cynthia C. Da Silva, Sérgio O. De Paula |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-05-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1826798 |
Similar Items
-
Production of Proteins prM/M and E of Dengue Virus-3 in <i>Pichia pastoris</i>: Simplified Purification and Evaluation of Their Use as Antigens in Serological Diagnosis of Dengue
by: Michelle D. O. Teixeira, et al.
Published: (2020-09-01) -
Natural immunogenic properties of bioinformatically predicted linear B-cell epitopes of dengue envelope and pre-membrane proteins
by: Mahesha N. Nadugala, et al.
Published: (2021-11-01) -
Development and biochemical characteristics of a monoclonal antibody against prM protein of Tembusu virus
by: Siming Zhu, et al.
Published: (2023-12-01) -
Mutation in West Nile Virus Structural Protein prM during Human Infection
by: Yaniv Lustig, et al.
Published: (2016-09-01) -
Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice
by: Kaihao Feng, et al.
Published: (2020-03-01)